The medicinal cannabis industry has evolved rapidly over the past decade and now generates over one billion dollars in annual revenue in Australia alone. In this environment, GMP compliance is not optional - it can be the difference between commercial success and product recall, with significant regulatory and reputational consequences.

Harbyne Consulting specialises in the practical navigation of GMP and regulatory frameworks, working across the TGA in Australia and regulatory authorities in Europe and North America. We don’t just interpret medicinal cannabis regulations - we translate them into workable, operational, and efficient quality systems that support growth rather than constrain it.

Compliance delivered with commercial reality in mind.
If you want to learn more, talk to us.